News
Piper Sandler Maintains Overweight on Keros Therapeutics, Maintains $105 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Truist Securities Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target
13 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target
1 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Keros Therapeutics Q4 EPS $(1.34) Beats $(1.37) Estimate
28 Feb 24
Earnings, News